Saccà Francesco

Saccà Francesco

Università degli Studi di Napoli Federico II - Napoli / Italy
Medical and Health Sciences / Neurology
AD Scientific Index ID: 1857583
University of Naples Federico II
person_outline Saccà Francesco's MOST POPULAR ARTICLES
1-) Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 studyL Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...The Lancet 391 (10127), 1263-1273, 20186912018
2-) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …JF Howard Jr, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, ...The Lancet Neurology 16 (12), 976-986, 20173902017
3-) Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trialJF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ...The Lancet Neurology 20 (7), 526-536, 20211732021
4-) Long‐term safety and efficacy of eculizumab in generalized myasthenia gravisS Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...Muscle & nerve 60 (1), 14-24, 20192022019
5-) SCA Functional Index: a useful compound performance measure for spinocerebellar ataxiaT Schmitz-Hubsch, P Giunti, DA Stephenson, C Globas, L Baliko, F Saccà, ...Neurology 71 (7), 486-492, 20081632008